FDA Approves LINZESS (VIDEO)

Fleishman-Hillard

Caption

FDA approves a drug for the treatment of both irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation in adults. Soundbites provided by Susan Lucak, MD, Columbia University Medical Center.

Credit

Courtesy Forest Laboratories, Inc., and Ironwood Pharmaceuticals, Inc.

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.